Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00544700
Recruitment Status : Active, not recruiting
First Posted : October 16, 2007
Last Update Posted : February 12, 2018
Information provided by (Responsible Party):
Swiss Group for Clinical Cancer Research